                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest reported) October 29, 2003
                                           ----------------

                            Advanced Biotherapy, Inc.
                           --------------------------
             (Exact name of registrant as specified in its chapter)

         Delaware                         0-26323                51-0402415
     ------------------            --------------------      ------------------
(State or other jurisdiction            (Commission            (IRS Employer
     of incorporation)                  File Number)         Identification No.)

6355 Topanga Canyon Boulevard, Suite 510
    Woodland Hills, California                                     91367
--------------------------------------------------------------------------------
(Address of principal executive offices)                         (Zip Code)

Registrant's telephone number, including area code (818) 883-6716
                                                   --------------

<PAGE>



Item 5.  OTHER EVENTS.

         The  Registrant   reported   beneficial   effects  of   investigational
antibodies to Interferon-Gamma in treating rheumatoid  arthritis at the American
College of  Rheumatology  67th Annual  Scientific  Meeting this week in Orlando,
Florida.


Item 7.  FINANCIAL STATEMENTS AND EXHIBITS

(c) Exhibits.

Designation     Description of Exhibit
-----------     ----------------------

99.1            Press Release dated 10/28/2003



                                   Signatures

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                    ADVANCED BIOTHERAPY, INC.
                                    (Registrant)


Date: October 29, 2003              By: /s/ Edmond Buccellato
                                        ------------------------------------
                                        Edmond Buccellato, President and CEO



                                INDEX TO EXHIBITS

Exhibit         Description
-------         -----------

99.1            Press Release dated 10/28/2003




